William Richard White, Chief Financial Officer at Akero Therapeutics, Inc. (AKRO), sold 196,668 shares at $27.21 ($5.3M) on 2024-08-26, disclosed to the SEC on 2024-08-29.
Scheduled sale ($5.3M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.21 | 18,116 | $493K | 9.3% |
| 2 | $27.21 | 18,116 | $493K | 9.3% |
| 3 | $27.21 | 24,372 | $663K | 12.5% |
| 4 | $27.21 | 24,372 | $663K | 12.5% |
| 5 | $27.21 | 32,671 | $889K | 16.7% |
| 6 | $27.21 | 32,671 |
| $889K |
| 16.7% |
| 7 | $26.41 | 23,175 | $612K | 11.5% |
| 8 | $26.41 | 23,175 | $612K | 11.5% |
| Total | $27.02 avg | 196,668 | $5.3M | 100% |
| Filing → |
| AKRO | SELL | 2025-06-12 | $151K | — | Filing → |
| AKRO | SELL | 2025-03-14 | $30K | — | Filing → |
| AKRO | SELL | 2024-12-12 | $173K | — | Filing → |